Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06245486
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-07
First Post:
2024-01-20
Brief Title:
Probiotc Lactobacillus Crispatus-M247 Crispact Supplementation in the Sterilization of High-risk Human Papilloma HPV-HR Viruses
Sponsor:
Liaquat University of Medical Health Sciences
Organization:
Liaquat University of Medical Health Sciences
Study Overview
Official Title:
Study on the Efficacy of Crispact Probiotic Containing Lactobacillus Crispatus M247 in the Sterilization of HPV-HR and in the Reconstitution of the Normal Vaginal Microbiota
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
There is growing scientific interest in probiotic supplementation as a possible therapy for clearing the human papillomavirus HPV infection and reducing the risk of developement of cervical cancer
Detailed Description:
This is a multicenter randomized longitudinal prospective parallel-group single-blind study aimed to investigate the efficacy of probiotic Crispact which contains 20 Bld CFUStick of Lactobacillus crispatus M247 in clearance of human papillomavirus HPV infection in healthy female who tested positive for human papillomavirus HPV infection
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None